Smith & Nephew SNATS Inc (SNN) - Total Assets

Latest as of December 2025: $10.46 Billion USD

Based on the latest financial reports, Smith & Nephew SNATS Inc (SNN) holds total assets worth $10.46 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Smith & Nephew SNATS Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Smith & Nephew SNATS Inc - Total Assets Trend (1985–2025)

This chart illustrates how Smith & Nephew SNATS Inc's total assets have evolved over time, based on quarterly financial data. See Smith & Nephew SNATS Inc net assets for net asset value and shareholders' equity analysis.

Smith & Nephew SNATS Inc - Asset Composition Analysis

Current Asset Composition (December 2025)

Smith & Nephew SNATS Inc's total assets of $10.46 Billion consist of 39.2% current assets and 60.8% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 5.3%
Accounts Receivable $1.43 Billion 13.7%
Inventory $2.12 Billion 20.2%
Property, Plant & Equipment $1.64 Billion 15.7%
Intangible Assets $882.00 Million 8.4%
Goodwill $3.11 Billion 29.7%

Asset Composition Trend (1985–2025)

This chart illustrates how Smith & Nephew SNATS Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Smith & Nephew SNATS Inc (SNN) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Smith & Nephew SNATS Inc's current assets represent 39.2% of total assets in 2025, a decrease from 67.9% in 1985.
  • Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, down from 20.9% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 20.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 29.7% of total assets.

Smith & Nephew SNATS Inc Competitors by Total Assets

Key competitors of Smith & Nephew SNATS Inc based on total assets are shown below.

Company Country Total Assets
Demant A/S
CO:DEMANT
Denmark Dkr39.07 Billion
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
SS Innovations International Inc. Common Stock
NASDAQ:SSII
USA $90.55 Million
Vieworks Co. Ltd
KQ:100120
Korea ₩351.89 Billion
Emvision Medical Devices Ltd
AU:EMV
Australia AU$24.94 Million
Respiri Ltd
AU:RSH
Australia AU$7.08 Million
Diagnostic Medical Systems SA
PA:ALDMS
France €62.52 Million
Implanet SA
PA:ALIMP
France €18.45 Million

Smith & Nephew SNATS Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.57 2.89 2.76
Quick Ratio 1.25 1.33 1.76
Cash Ratio 0.00 0.00 0.00
Working Capital $2.51 Billion $2.89 Billion $2.98 Billion

Smith & Nephew SNATS Inc - Advanced Valuation Insights

This section examines the relationship between Smith & Nephew SNATS Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.53
Latest Market Cap to Assets Ratio 1.22
Asset Growth Rate (YoY) 1.0%
Total Assets $10.46 Billion
Market Capitalization $12.71 Billion USD

Valuation Analysis

Above Book Valuation: The market values Smith & Nephew SNATS Inc's assets above their book value (1.22x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Smith & Nephew SNATS Inc's assets grew by 1.0% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Smith & Nephew SNATS Inc (1985–2025)

The table below shows the annual total assets of Smith & Nephew SNATS Inc from 1985 to 2025.

Year Total Assets Change
2025-12-31 $10.46 Billion +0.99%
2024-12-31 $10.35 Billion +3.67%
2023-12-31 $9.99 Billion +0.21%
2022-12-31 $9.97 Billion -8.74%
2021-12-31 $10.92 Billion -0.84%
2020-12-31 $11.01 Billion +18.42%
2019-12-31 $9.30 Billion +15.39%
2018-12-31 $8.06 Billion +2.45%
2017-12-31 $7.87 Billion +7.11%
2016-12-31 $7.34 Billion +2.47%
2015-12-31 $7.17 Billion -1.90%
2014-12-31 $7.31 Billion +25.55%
2013-12-31 $5.82 Billion +3.14%
2012-12-31 $5.64 Billion +18.85%
2011-12-31 $4.75 Billion +0.30%
2010-12-31 $4.73 Billion +3.68%
2009-12-31 $4.57 Billion +1.26%
2008-12-31 $4.51 Billion +1.05%
2007-12-31 $4.46 Billion +38.07%
2006-12-31 $3.23 Billion +8.57%
2005-12-31 $2.98 Billion +1.94%
2004-12-31 $2.92 Billion +31.35%
2003-12-31 $2.22 Billion +11.52%
2002-12-31 $1.99 Billion +24.66%
2001-12-31 $1.60 Billion +11.22%
2000-12-31 $1.44 Billion -9.36%
1999-12-31 $1.59 Billion +5.53%
1998-12-31 $1.50 Billion +5.29%
1997-12-31 $1.43 Billion -1.00%
1996-12-31 $1.44 Billion +13.29%
1995-12-31 $1.27 Billion -3.74%
1994-12-31 $1.32 Billion +1.15%
1993-12-31 $1.31 Billion -2.80%
1992-12-31 $1.34 Billion -15.04%
1991-12-31 $1.58 Billion +3.19%
1990-12-31 $1.53 Billion +13.35%
1989-12-31 $1.35 Billion +6.28%
1988-12-31 $1.27 Billion +3.72%
1987-12-31 $1.23 Billion +38.14%
1986-12-31 $888.50 Million +38.10%
1985-12-31 $643.40 Million --

About Smith & Nephew SNATS Inc

NYSE:SNN USA Medical Devices
Market Cap
$12.71 Billion
Market Cap Rank
#1850 Global
#698 in USA
Share Price
$29.77
Change (1 day)
-0.57%
52-Week Range
$28.73 - $38.70
All Time High
$45.52
About

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more